We specialise in providing actionable insights in high-impact therapeutic areas to help answer your most pressing questions. Our services include:

  • Drug uptake and epidemiology analysis​
  • Standard of care and patient pathway analysis​
  • Therapy impact analysis on outcomes and costs

Check out our current projects and sign up below.


RSV Observatory

Respiratory Syncytial Virus (RSV) is a frequent cause of seasonal acute respiratory infection (ARI). The impact of RSV on healthcare is likely to be underestimated and there are significant knowledge gaps around RVS. During this project, data on the diagnostics and treatment of RSV are gathered from hospitals across Europe. The ultimate goal is to, by analysing these data, looking at relevant variations between hospitals and countries and identifying the impact of those differences on RSV therapy outcomes and costs, reach actionable insights to improve the care for RSV patients.

Drug use & epidemiology analysis

We provide insights into drug use and epidemiology analysis to answer questions related to medication usage, such as identifying the types and number of patients using a drug and determining eligibility.

Examples of projects include epidemiology studies, patient group analysis and segmentation, and treatment pattern analysis in medicine.

Psoriasis Observatory

There are currently many advancements in how psoriasis is being and can be treated. Novel treatments modulating the inflammatory pathways in psoriasis have been introduced, and several biosimilars of TNFi drugs are being introduced. This could impact pathways, clinical outcomes and costs.

This diversity in treatment could lead to unclarity on what is the best choice in which case, on what outcomes are to be expected with what specific care path and what the associated cost will be.

To gather information on the treatment of psoriasis across European hospitals, we have established the Psoriasis Observatory. The aim is to analyse the gathered data and use the insights to characterise the psoriasis care pathways and their changes over time. We also intend to analyse variations in care approaches between hospitals and countries, as well as identify the impact of different care pathways on psoriasis therapy outcomes and costs.

Standard of care & patient pathway analysis

We provide insights into the standard of care and patient pathway analysis to answer questions such as how patients are treated in hospitals.

Examples of projects include analysing patient pathways, ensuring adherence to treatment guidelines, segmenting patient groups by treatment modality.

United Kingdom

Chronic kidney disease (CKD) and Anaemia

We provide insights to evaluate the treatment pathways of CKD patients at different stages with Anaemia, overlaying pathology results to review the clinical impact of treatment.

NICE (The National Institute for Health and Care Excellence)

In collaboration with NICE we provide insights to evaluate patients with Renal Cell Carcinoma (RCC) treatment pathways.

The Netherlands

Herpes Zoster

Patients with reduced immune system effectiveness are at increased risk of Herpes Zoster (HZ) and serious complications, such as postherpetic neuralgia (PHN). This negatively affects the quality of life of these patients, while this can be prevented by vaccination against HZ.

We provide insight into the high-risk population and where there are opportunities to optimise the care for these patients.

The Targeted Treatment Observatory (TTO)

The Targeted Treatment Observatory maps real-world evidence of molecular diagnostics and treatment data of cancer patients.

We developed a natural language processing model to facilitate automated extraction of mutation status from pathology reports. By linking these data to administrative databases, we create an overview that assists healthcare providers in tracking the treatment pathway of cancer patients and improving healthcare.

the network for forward thinking healthcare providers

ARWEN is powered by